tetroxoprim has been researched along with trimethoprim in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (77.78) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richards, WG; So, SS | 1 |
| Hansch, C; Li, RL; Poe, M; Selassie, CD | 1 |
| Debnath, G; Fang, ZX; Hansch, C; Kaufman, BT; Klein, TE; Langridge, R; Li, RL; Selassie, CD | 1 |
| Li, RL; Poe, M | 1 |
| Doweyko, AM | 1 |
| Fang, ZX; Hansch, C; Kaufman, BT; Klein, T; Langridge, R; Li, RL; Selassie, CD | 1 |
| Coats, EA; Genther, CS; Hansch, C; Selassie, CD; Strong, CD | 1 |
| Dias, CB; Hansch, C; Khwaja, TA; Pentecost, S; Selassie, CD | 1 |
| Blaney, JM; Hansch, C; Langridge, R; Li, R | 1 |
| Dietrich, SW; Hansch, C; Li, RL | 1 |
| Aig, E; Bushby, SR; Ferone, R; Phillips, AP; Rauckman, BS; Roth, B; Sigel, CW; Strelitz, JZ | 1 |
| Hansch, C; Kaufman, BT; Li, R | 1 |
| Dias, CB; Hansch, C; Khwaja, TA; Li, R; Selassie, CD | 1 |
| Queener, SF | 1 |
| Loukas, YL | 1 |
| Aschhoff, HS; Vergin, H | 1 |
| De leenheer, AP; Léger, F; Nelis, HJ; Sorgeloos, P | 1 |
| Armengaud, H; Bishop-Freudling, GB; Foing, N; Szelenyi, I; van Tho, T; Vergin, H | 1 |
| Iversen, P; Madsen, PO; Vergin, H | 1 |
| Bishop-Freudling, GB; Merk, K; Szelenyi, I; Vergin, H | 1 |
| Fell, JJ; Grimm, H | 1 |
| Hengstmann, JH | 1 |
| Schlöbe, R; Thijssen, HH | 1 |
| Iversen, P; Madsen, PO | 1 |
| Hahn, H; Kirov, A | 1 |
| Ascalone, V | 1 |
| Gabriëls, G; Greven, J; Stockem, E | 1 |
2 review(s) available for tetroxoprim and trimethoprim
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |
Pharmacokinetics of trimethoprim and tetroxoprim. A review.
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Chemical Phenomena; Chemistry; Humans; Kidney Diseases; Kinetics; Pyrimidines; Tissue Distribution; Trimethoprim | 1982 |
25 other study(ies) available for tetroxoprim and trimethoprim
| Article | Year |
|---|---|
Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors.
Topics: Drug Design; Folic Acid Antagonists; Neural Networks, Computer; Pyrimidines; Regression Analysis; Structure-Activity Relationship | 1992 |
On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
Topics: Diamines; Escherichia coli; Folic Acid Antagonists; Kinetics; Lacticaseibacillus casei; Molecular Structure; Protein Binding; Pyrimidines; Structure-Activity Relationship | 1991 |
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
Topics: Animals; Chemical Phenomena; Chemistry; Chickens; Drug Design; Folic Acid Antagonists; Lacticaseibacillus casei; Liver; Pyrimidines; Structure-Activity Relationship; X-Ray Diffraction | 1989 |
Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
Topics: Binding Sites; Escherichia coli; Folic Acid Antagonists; Pyrimidines; Structure-Activity Relationship; Trimethoprim | 1988 |
The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.
Topics: Binding Sites; Binding, Competitive; Chemical Phenomena; Chemistry; Enzyme Inhibitors; Escherichia coli; Folic Acid Antagonists; Lactoylglutathione Lyase; Lyases; Microcomputers; Models, Chemical; Models, Molecular; Molecular Conformation; Saccharomyces cerevisiae; Structure-Activity Relationship; Thermodynamics | 1988 |
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
Topics: Animals; Chickens; Crystallography; Enzyme Inhibitors; Folic Acid Antagonists; Liver; Mathematics; Models, Molecular; Pyrimidines; Structure-Activity Relationship; Trimethoprim; X-Ray Diffraction | 1986 |
Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
Topics: Biological Transport, Active; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Escherichia coli; Folic Acid Antagonists; Lacticaseibacillus casei; Mathematics; Methotrexate; Pyrimethamine; Pyrimidines; Structure-Activity Relationship; Triazines | 1985 |
Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Chickens; Drug Resistance; Folic Acid Antagonists; Humans; Leukemia L5178; Leukemia, Experimental; Mathematics; Methotrexate; Mice; Structure-Activity Relationship; Triazines | 1984 |
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-act
Topics: Binding Sites; Computers; Escherichia coli; Folic Acid Antagonists; Lacticaseibacillus casei; Models, Molecular; Pyrimidines; Structure-Activity Relationship; X-Ray Diffraction | 1982 |
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
Topics: Animals; Cattle; Escherichia coli; Folic Acid Antagonists; In Vitro Techniques; Kinetics; Liver; Pyrimidines; Structure-Activity Relationship | 1981 |
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 5. 3',5'-Dimethoxy-4'-substituted-benzyl analogues of trimethoprim.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Dogs; Drug Evaluation; Escherichia coli; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trimethoprim | 1981 |
A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
Topics: Animals; Cattle; Chickens; Folic Acid Antagonists; In Vitro Techniques; Kinetics; Liver; Pyrimidines; Species Specificity | 1982 |
Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chemistry, Pharmaceutical; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Methotrexate; Mice; Pyrimidines; Solubility | 1982 |
Adaptive neuro-fuzzy inference system: an instant and architecture-free predictor for improved QSAR studies.
Topics: Algorithms; Folic Acid Antagonists; Multivariate Analysis; Pyrimidines; Quantitative Structure-Activity Relationship; Regression Analysis; Tetrahydrofolate Dehydrogenase | 2001 |
Tetroxoprim--a new inhibitor of bacterial dihydrofolate reductase.
Topics: Animals; Anti-Bacterial Agents; Cattle; Escherichia coli; Folic Acid Antagonists; In Vitro Techniques; Kinetics; Liver; NADP; Pyrimidines; Trimethoprim | 1979 |
Liquid chromatographic determination of efficacy of incorporation of trimethoprim and sulfamethoxazole in brine shrimp (Artemia spp.) used for prophylactic chemotherapy of fish.
Topics: Animals; Anti-Infective Agents; Artemia; Chromatography, Liquid; Communicable Disease Control; Pyrimidines; Reference Standards; Sulfamethoxazole; Sulfisoxazole; Trimethoprim | 1991 |
Diffusion of metioprim, tetroxoprim and sulphadiazine in the cerebrospinal fluid of dogs with healthy meninges and dogs with experimental meningitis.
Topics: Animals; Anti-Infective Agents; Blood-Brain Barrier; Dogs; Female; Half-Life; Infusions, Parenteral; Injections, Intravenous; Kinetics; Male; Meningitis; Pyrimidines; Staphylococcal Infections; Sulfadiazine; Trimethoprim | 1984 |
Renal handling and lymph concentration of tetroxoprim and metioprim: an experimental study in dogs.
Topics: Animals; Anti-Infective Agents; Dogs; Glomerular Filtration Rate; Kidney; Lymph; Male; Pyrimidines; Trimethoprim | 1984 |
Pancreatic secretion of benzylpyrimidines. Experimental studies in dogs.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Dogs; Female; Hydrogen-Ion Concentration; Male; Pancreas; Pyrimidines; Time Factors; Trimethoprim | 1982 |
[Antibacterial comparison of sulfonamide combinations].
Topics: Drug Combinations; Humans; Microbial Sensitivity Tests; Pyrimidines; Sulfadiazine; Sulfamethoxazole; Sulfamoxole; Sulfanilamides; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1980 |
Quantitative thin-layer chromatography of trimethoprim and tetroxoprim using fluorescence densitometry.
Topics: Chromatography, Thin Layer; Female; Fluorescence; Humans; Pyrimidines; Reference Values; Time Factors; Trimethoprim | 1982 |
Trimethoprim, metioprim, tetroxoprim, and RO 10-5970 in canine bone.
Topics: Animals; Bone and Bones; Dogs; Male; Pyrimidines; Trimethoprim | 1982 |
[Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
Topics: Anti-Bacterial Agents; Bacteria; Drug Combinations; Microbial Sensitivity Tests; Pyrimidines; Sulfadiazine; Sulfamethoxazole; Trimethoprim | 1980 |
Assay of trimethoprim, sulfadiazine and its N4-acetyl metabolite in biological fluids by normal-phase high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Humans; Pyrimidines; Sulfadiazine; Time Factors; Trimethoprim | 1981 |
Potassium-sparing renal effects of trimethoprim and structural analogues.
Topics: Animals; Anti-Infective Agents; Blood Pressure; Chlorides; Dose-Response Relationship, Drug; Folic Acid Antagonists; Glomerular Filtration Rate; Kidney; Male; Methotrexate; Potassium; Pyrimethamine; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium; Time Factors; Trimethoprim | 2000 |